The US Court of Appeals for the Federal Circuit in Washington, DC has ruled that Apple should have been awarded an injunction against Samsung during the second smartphone patent trial. In its ruling affirming the embargo and pointing out errors by the lower court, the appeals court declared that "Apple does not seek to enjoin the sale of lifesaving drugs, but to prevent Samsung from profiting from the unauthorized use of infringing features in its cellphones and tablets."
